Apr 18 |
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
|
Apr 9 |
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Apr 1 |
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
|
Mar 4 |
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
|
Mar 1 |
Shattuck Labs GAAP EPS of -$0.41
|
Feb 29 |
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
|
Feb 26 |
Shattuck Labs Announces Participation in Upcoming March Conferences
|
Feb 14 |
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
|
Feb 14 |
Two biotech/pharma stocks to watch - STTK, KALV
|
Feb 13 |
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
|